Lv41
781 积分 2021-02-20 加入
ANGPTL4 Inhibition in Adults with Elevated Triglyceride Levels
11分钟前
已完结
Safety and efficacy of a novel ANGPTL4 inhibitory antibody for lipid lowering: results from phase 1 and phase 1b/2a clinical studies
11分钟前
已完结
nalysis and prediction of globally and Chinese epidemiological trends of inflammatory bowel disease from 1990 to 2021
23天前
已完结
Emerging pharmacotherapies for androgenetic alopecia
2个月前
已完结
A phase II study of antibody-drug conjugate, TAK-264 (MLN0264) in previously treated patients with advanced or metastatic pancreatic adenocarcinoma expressing guanylyl cyclase C
3个月前
已完结
Durability of Response to Icotrokinra in Adults With Moderate-to-Severe Plaque Psoriasis: One-Year Results From the Phase 3, Placebo- and Active Comparator-Controlled ICONIC-ADVANCE 1 & ICONIC-ADVANCE 2 Trials
3个月前
已完结
Safety and pharmacokinetics of SOR102, an oral bispecific inhibitor of TNF and interleukin-23 in healthy participants and patients with ulcerative colitis: a first-in-human, double-blind, randomised, placebo-controlled, phase 1 trial
3个月前
已完结
Efficacy and safety of tezepelumab versus placebo in adults with moderate to very severe chronic obstructive pulmonary disease (COURSE): a randomised, placebo-controlled, phase 2a trial
3个月前
已完结
Dupilumab for COPD with Blood Eosinophil Evidence of Type 2 Inflammation
3个月前
已完结
Dupilumab for COPD with Type 2 Inflammation Indicated by Eosinophil Counts
3个月前
已完结
皖公网安备34019202002308
